Clinical Trials Browser

Phase 2 × Completed × Ovarian Cancer Recurrent × Clear all

NCT04175470 2025-01-03

Bevacizumab and Tocotrienol in Recurrent Ovarian Cancer

Phase 2 Completed

Ovarian Cancer Recurrent

NCT01332656 2015-12-21

OPSALIN

Phase 2 Completed

Ovarian Cancer Recurrent

NCT01485848 2014-06-10

ESP2011-002

Phase 2 Completed

Ovarian Cancer Recurrent